• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CEO
Click for more information
0.00% 4.2¢

C @ LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CEO
rencap valuation 80c then blue sky $8 		20/12/11 15 8.8K
20/12/11 Last post  lexiconfs Comments Created with Sketch.  15  Views Created with Sketch.  8.8K 
CEO
placement 		15/12/11 22 6.2K
15/12/11 Last post  blueskybaby Comments Created with Sketch.  22  Views Created with Sketch.  6.2K 
CEO
new thread drg up and running 		15/12/11 0 779
15/12/11 Last post  hydrogen Comments Created with Sketch.  0  Views Created with Sketch.  779 
CEO
thats all folks 		13/12/11 0 729
13/12/11 Last post  garyrm1973 Comments Created with Sketch.  0  Views Created with Sketch.  729 
CEO
capital raising and mongolian coal licence acq 		13/12/11 0 597
13/12/11 Last post  Sheeza69 Comments Created with Sketch.  0  Views Created with Sketch.  597 
CEO
Ann: Appendix 3B 		13/12/11 0 847
13/12/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  847 
CEO
Ann: Capital Raising and Mongolian Coal Licence A 		13/12/11 0 999
13/12/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  999 
CEO
tinkler to takeover ceo.... 		13/12/11 1 1.2K
13/12/11 Last post  Opto Comments Created with Sketch.  1  Views Created with Sketch.  1.2K 

See All Discussions arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.